eza total rna kit i (Omega Bio Tek)
90
Structured Review
Omega Bio Tek
eza total rna kit i
Eza Total Rna Kit I, supplied by Omega Bio Tek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eza+total+rna+kit+i/eza+total+rna+kit+i/pm33793232-342-9-14
Average 90 stars, based on 1 article reviews
Eza Total Rna Kit I, supplied by Omega Bio Tek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eza+total+rna+kit+i/eza+total+rna+kit+i/pm33793232-342-9-14
Average 90 stars, based on 1 article reviews
eza total rna kit i - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in mice Article Snippet: After discarding the supernatant, total RNA was extracted using the Article Title: l-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ Article Snippet: Thyroid hormones (THs) operate numerous physiological processes through modulation of the nuclear thyroid hormone receptors and several other proteins.. We report direct activation of the nuclear peroxisome proliferatoractivated receptor gamma (PPARγ) and retinoid X receptor (RXR) by classical and non-classical THs as another molecular activity of THs.. The T4 metabolite TETRAC was the most active TH on PPARγ with nanomolar potency and binding affinity. Article Title: A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in mice Article Snippet: After discarding the supernatant, total RNA was extracted using the Article Title: Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics. Article Snippet: The retinoid X receptors (RXR) are ligandactivated transcription factors involved in multiple regulatory networks as universal heterodimer partners for nuclear receptors.. Despite their high therapeutic potential in many pathologies, targeting of RXR has only been exploited in cancer treatment as the currently available RXR agonists suffer from exceptional lipophilicity, poor pharmacokinetics (PK), and adverse effects.. Aiming to overcome the limitations and to provide improved RXR ligands, we developed a new potent RXR ligand chemotype based on the nonsteroidal anti-inflammatory drug oxaprozin. |